Anny T Fenton1, Terresa J Eun2, Jack A Clark3, Rebecca B Perkins2,4. 1. a Harvard University , Cambridge , MA , USA. 2. b Boston Medical Center , Boston , MA , USA. 3. c Boston University School of Public Health , Boston , MA , USA. 4. d Boston University School of Medicine , Boston , MA , USA.
Abstract
BACKGROUND: Appropriate provider recommendation is crucial to raising HPV vaccination uptake, yet scant research has explored actual conversations between providers and parents, the effect of parental pre-visit vaccine intention on vaccination, or the effect of conversation style on parental satisfaction with that conversation. METHODS: We analyzed 146 audio-recorded clinical encounters between providers, parents/guardians, and HPV vaccine-eligible adolescents, from May 2015 to March 2017, at eight practices in Northeastern U.S. Parents completed pre-visit measures of intent to vaccinate and post-visit assessments of satisfaction with vaccine conversations. We qualitatively analyzed transcribed audio recordings and evaluated associations between providers' vaccine introductions and vaccine receipt. RESULTS: Provider recommendations were empirically defined as "indicated" (clear recommendation that the child receive HPV vaccination at that visit), "elective" (vaccination presented as optional), or "contraindicated" (delay recommended). The vaccination rates were 87%, 68%, and 0% following "indicated," "elective," and "contraindicated" presentations respectively. Providers' statements attesting to the vaccine's value to the child did not affect receipt. Parental pre-visit intent to vaccinate was associated with vaccine receipt: 100% for likely/very likely compared to 28% for very unlikely. The association between vaccine recommendation style and vaccine receipt was most pronounced with undecided parents, with 92% accepting vaccination after an "indicated" recommendation vs. 68% after an "elective" recommendation. Satisfaction with vaccine conversations was high regardless of recommendation style. CONCLUSIONS: The results suggest that the words used to introduce HPV vaccination have the potential to inform parents' HPV vaccination decisions. Providers should be encouraged to simply state, "Your child is due for the HPV vaccine today."
BACKGROUND: Appropriate provider recommendation is crucial to raising HPV vaccination uptake, yet scant research has explored actual conversations between providers and parents, the effect of parental pre-visit vaccine intention on vaccination, or the effect of conversation style on parental satisfaction with that conversation. METHODS: We analyzed 146 audio-recorded clinical encounters between providers, parents/guardians, and HPV vaccine-eligible adolescents, from May 2015 to March 2017, at eight practices in Northeastern U.S. Parents completed pre-visit measures of intent to vaccinate and post-visit assessments of satisfaction with vaccine conversations. We qualitatively analyzed transcribed audio recordings and evaluated associations between providers' vaccine introductions and vaccine receipt. RESULTS: Provider recommendations were empirically defined as "indicated" (clear recommendation that the child receive HPV vaccination at that visit), "elective" (vaccination presented as optional), or "contraindicated" (delay recommended). The vaccination rates were 87%, 68%, and 0% following "indicated," "elective," and "contraindicated" presentations respectively. Providers' statements attesting to the vaccine's value to the child did not affect receipt. Parental pre-visit intent to vaccinate was associated with vaccine receipt: 100% for likely/very likely compared to 28% for very unlikely. The association between vaccine recommendation style and vaccine receipt was most pronounced with undecided parents, with 92% accepting vaccination after an "indicated" recommendation vs. 68% after an "elective" recommendation. Satisfaction with vaccine conversations was high regardless of recommendation style. CONCLUSIONS: The results suggest that the words used to introduce HPV vaccination have the potential to inform parents' HPV vaccination decisions. Providers should be encouraged to simply state, "Your child is due for the HPV vaccine today."
Entities:
Keywords:
Human Papillomavirus (HPV) vaccine; patient satisfaction; provider-parent communication
Authors: Paul M Darden; David M Thompson; James R Roberts; Jessica J Hale; Charlene Pope; Monique Naifeh; Robert M Jacobson Journal: Pediatrics Date: 2013-03-18 Impact factor: 7.124
Authors: Susan T Vadaparampil; Teri L Malo; Steven K Sutton; Karla N Ali; Jessica A Kahn; Alix Casler; Daniel Salmon; Barbara Walkosz; Richard G Roetzheim; Gregory D Zimet; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-08-02 Impact factor: 4.254
Authors: Douglas J Opel; Rita Mangione-Smith; Jeffrey D Robinson; John Heritage; Victoria DeVere; Halle S Salas; Chuan Zhou; James A Taylor Journal: Am J Public Health Date: 2015-03-19 Impact factor: 9.308
Authors: Lynne Sturm; Kelly Donahue; Monica Kasting; Amit Kulkarni; Noel T Brewer; Gregory D Zimet Journal: J Adolesc Health Date: 2017-04-25 Impact factor: 5.012
Authors: Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer Journal: Vaccine Date: 2016-01-24 Impact factor: 3.641
Authors: Tanja Y Walker; Laurie D Elam-Evans; James A Singleton; David Yankey; Lauri E Markowitz; Benjamin Fredua; Charnetta L Williams; Sarah A Meyer; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2017-08-25 Impact factor: 17.586
Authors: Rebecca B Perkins; Bolanle Banigbe; Anny T Fenton; Amanda K O'Grady; Emily M Jansen; Judith L Bernstein; Natalie P Joseph; Terresa J Eun; Dea L Biancarelli; Mari-Lynn Drainoni Journal: Hum Vaccin Immunother Date: 2020-05-13 Impact factor: 3.452
Authors: Terresa J Eun; Amresh Hanchate; Anny T Fenton; Jack A Clark; Marisa N Aurora; Mari-Lynn Drainoni; Rebecca B Perkins Journal: Hum Vaccin Immunother Date: 2019-04-16 Impact factor: 3.452
Authors: Stephanie A S Staras; Carma L Bylund; Shivani Desai; Christopher A Harle; Eric Richardson; Georges E Khalil; Lindsay A Thompson Journal: PEC Innov Date: 2022-12
Authors: Anny T H R Fenton; Chelsea Orefice; Terresa J Eun; Dea Biancarelli; Amresh Hanchate; Mari-Lynn Drainoni; Rebecca B Perkins Journal: Vaccine Date: 2021-01-12 Impact factor: 3.641
Authors: Brigid K Grabert; Jennifer Heisler-MacKinnon; Amy Liu; Marjorie A Margolis; Elizabeth D Cox; Melissa B Gilkey Journal: Hum Vaccin Immunother Date: 2021-06-21 Impact factor: 4.526